Clinical Trials Browser

Phase 2 × Has results × darolutamide × Clear all

NCT05526248 2026-03-11

ARAMON

Phase 2 Completed

28 enrolled 14 charts

Biochemically Recurrent Prostate Cancer

NCT04157088 2023-08-04

DaroAcT

Phase 2 Terminated

30 enrolled 25 charts

Prostatic Neoplasms, Castration-Resistant

NCT01429064 2017-02-20

Safety and Tolerability of ODM-201 in Castrate Resistant Prostate Cancer; Extension Study to Study 3104001

Phase 2 Completed

76 enrolled 9 charts

Prostatic Neoplasms